BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16382376)

  • 1. Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):371-2. PubMed ID: 16382376
    [No Abstract]   [Full Text] [Related]  

  • 2. The CATIE study and its implications for antipsychotic drug use.
    Janicak PG
    Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Open studies in comparison to controlled studies in testing of neuroleptics].
    Pajonk FG; Holzbach R; Naber D
    Fortschr Neurol Psychiatr; 2000 Jul; 68(7):313-20. PubMed ID: 10945157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perazine in the treatment of psychotic disorders--research review].
    Kiejna A
    Psychiatr Pol; 2010; 44(3):427-34. PubMed ID: 20672521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the limitations of the CATIE study.
    Kasper S; Winkler D
    World J Biol Psychiatry; 2006; 7(2):126-7. PubMed ID: 16684687
    [No Abstract]   [Full Text] [Related]  

  • 6. [New "atypical" neuroleptics -- the emperor's new clothes?].
    Dose M
    Psychiatr Prax; 2003 Jan; 30(1):1-3. PubMed ID: 12524575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs.
    Angst J; Bech P; Bobon D; Engel R; Hippius H; Janzen GJ; Lecrubier Y; Lingjaerde O; Möller HJ; Montgomery S
    Pharmacopsychiatry; 1991 Sep; 24(5):149-52. PubMed ID: 1685571
    [No Abstract]   [Full Text] [Related]  

  • 9. Discontinuation of antipsychotic medication-time to rethink trial design.
    Speyer H; Begemann M; Albert N; Weller A; Nordentoft M; Veling W; Sommer IE; Allott K; Killackey E
    Lancet Psychiatry; 2020 Oct; 7(10):841-842. PubMed ID: 32949515
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.
    Stroup TS; Alves WM; Hamer RM; Lieberman JA
    Nat Rev Drug Discov; 2006 Feb; 5(2):133-46. PubMed ID: 16518380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipsychotics and pregnancy: a clinical case].
    Pignatelli AM; Di Fabio F; Ferracuti S; Biondi M
    Riv Psichiatr; 2009; 44(5):299-308. PubMed ID: 20066817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
    Nasrallah HA
    J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
    [No Abstract]   [Full Text] [Related]  

  • 14. [7 years of experience with delayed action neuroleptics].
    Noguera Hosta R; Rendueles de Olmedo G
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):293-8. PubMed ID: 31066
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sexuality and antipsychotics].
    Kinzl JF
    Neuropsychiatr; 2008; 22(1):49-50. PubMed ID: 18548787
    [No Abstract]   [Full Text] [Related]  

  • 16. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pro and contra: basic precedence of atypical neuroleptics].
    Naber D; Dose M
    Psychiatr Prax; 2005 May; 32(4):163-6. PubMed ID: 15852207
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atypical antipsychotic-induced weight gain].
    Godlewska BR; Olajossy-Hilkesberger L; Marmurowska-Michałowska H; Olajossy M; Landowski J
    Psychiatr Pol; 2006; 40(5):995-1007. PubMed ID: 17217241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
    Tandon R; Carpenter WT; Davis JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642
    [No Abstract]   [Full Text] [Related]  

  • 20. [25 years antipsychotics: back to the future?].
    Denys D; de Haan L
    Tijdschr Psychiatr; 2008; 50 Spec no.():105-9. PubMed ID: 19067308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.